Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2015, Article ID 789806, 3 pages
http://dx.doi.org/10.1155/2015/789806
Case Report

Primary Small Cell Carcinoma in Urinary Bladder: A Rare Case

1Turgut Özal Medical Center, Department of Urology, Malatya, Turkey
2Turgut Özal Medical Center, Department of Pathology, Malatya, Turkey

Received 18 August 2015; Accepted 28 October 2015

Academic Editor: Michele Gallucci

Copyright © 2015 Ahmet Çamtosun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Zhao and E. A. Flynn, “Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy,” Archives of Pathology and Laboratory Medicine, vol. 136, no. 11, pp. 1451–1459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Shahab, “Extrapulmonary small cell carcinoma of the bladder,” Seminars in Oncology, vol. 34, no. 1, pp. 15–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. N. Church and A. Bahl, “Clinical review—small cell carcinoma of the bladder,” Cancer Treatment Reviews, vol. 32, no. 8, pp. 588–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. F. Cramer, M. Aikawa, and M. Cebelin, “Neurosecretory granules in small cell invasive carcinoma of the urinary bladder,” Cancer, vol. 47, no. 4, pp. 724–730, 1981. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Mazzucchelli, D. Morichetti, A. Lopez-Beltran et al., “Neuroendocrine tumours of the urinary system and male genital organs: clinical significance,” BJU International, vol. 103, no. 11, pp. 1464–1470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. R. Williamson, S. Zhang, J. L. Yao et al., “ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin,” Modern Pathology, vol. 24, no. 8, pp. 1120–1127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Wang, S. Zhang, G. T. MacLennan et al., “Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder,” Clinical Cancer Research, vol. 13, no. 3, pp. 953–957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. H. Abbosh, M. Wang, J. N. Eble et al., “Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder,” Modern Pathology, vol. 21, no. 3, pp. 355–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Cheng, C.-X. Pan, X. J. Yang et al., “Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients,” Cancer, vol. 101, no. 5, pp. 957–962, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Mackey, H.-J. Au, J. Hugh, and P. Venner, “Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival,” Journal of Urology, vol. 159, no. 5, pp. 1624–1629, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. A. O. Siefker-Radtke, C. P. Dinney, N. A. Abrahams et al., “Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience,” Journal of Urology, vol. 172, no. 2, pp. 481–484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Lohrisch, N. Murray, T. Pickles, and L. Sullivan, “Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation,” Cancer, vol. 86, no. 11, pp. 2346–2352, 1999. View at Publisher · View at Google Scholar · View at Scopus